Cell Division- Ch 5
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Meiotic Prophase Abnormalities and Metaphase Cell Death in MLH1-Deficient Mouse Spermatocytes: Insights Into Regulation of Spermatogenic Progress
Developmental Biology 249, 85–95 (2002) doi:10.1006/dbio.2002.0708 Meiotic Prophase Abnormalities and Metaphase Cell Death in MLH1-Deficient Mouse Spermatocytes: Insights into Regulation of Spermatogenic Progress Shannon Eaker,1 John Cobb,2 April Pyle, and Mary Ann Handel3 Department of Biochemistry and Cellular and Molecular Biology, University of Tennessee, Knoxville, Tennessee 37996 The MLH1 protein is required for normal meiosis in mice and its absence leads to failure in maintenance of pairing between bivalent chromosomes, abnormal meiotic division, and ensuing sterility in both sexes. In this study, we investigated whether failure to develop foci of MLH1 protein on chromosomes in prophase would lead to elimination of prophase spermatocytes, and, if not, whether univalent chromosomes could align normally on the meiotic spindle and whether metaphase spermatocytes would be delayed and/or eliminated. In spite of the absence of MLH1 foci, no apoptosis of spermatocytes in prophase was detected. In fact, chromosomes of pachytene spermatocytes from Mlh1؊/؊ mice were competent to condense metaphase chromosomes, both in vivo and in vitro. Most condensed chromosomes were univalents with spatially distinct FISH signals. Typical metaphase events, such as synaptonemal complex breakdown and the phosphorylation of Ser10 on histone H3, occurred in Mlh1؊/؊ spermatocytes, suggesting that there is no inhibition of onset of meiotic metaphase in the face of massive chromosomal abnormalities. However, the condensed univalent chromosomes did not align correctly onto the spindle apparatus in the majority of Mlh1؊/؊ spermatocytes. Most meiotic metaphase spermatocytes were characterized with bipolar spindles, but chromosomes radiated away from the microtubule-organizing centers in a prometaphase-like pattern rather than achieving a bipolar orientation. -
Keystone Review Module B BIO.B.1.1 – Describe the Three Stages of the Cell Cycle: Interphase, Nuclear Division, Cytokinesis
Keystone Review Module B BIO.B.1.1 – Describe the three stages of the cell cycle: interphase, nuclear division, cytokinesis. ● Describe the events that occur during the cell cycle: interphase, nuclear division, and cytokinesis. ● Compare the processes and outcomes of mitotic and meiotic nuclear division. Which statement BEST describes the phase of the cell cycle shown? A. The cell is in prophase of mitosis because the number of chromosomes has doubled. B. The cell is in prophase I of meiosis because of the number of chromosomes has doubled. C. The cell is in telophase of mitosis because the cell is separating and contains two copies of each chromosome. D. The cell is in telophase of meiosis because the cell is separating and contains two copies of each chromosome. Answer - C A. Incorrect - The cell is not in prophase. This is obvious as the cell contains two nuclei, a condition which only occurs in telophase. B. Incorrect - The cell is not in prophase. This is obvious as the cell contains two nuclei, a condition which only occurs in telophase. C. Correct - The cell is in telophase, which can be seen from the two nuclei. Only telophase of mitosis includes two copies of each chromosome. D. Incorrect - The cell is in telophase, but in meiosis each cell contains only 1 copy of each chromosome. Mitosis and meiosis are processes by which animal and plant cells divide. Which statement best describes a difference between mitosis and meiosis? A. Meiosis is a multi-step process. B. Mitosis occurs only in eukaryotic cells. C. Meiosis is used in the repair of an organism. -
RASSF1A Interacts with and Activates the Mitotic Kinase Aurora-A
Oncogene (2008) 27, 6175–6186 & 2008 Macmillan Publishers Limited All rights reserved 0950-9232/08 $32.00 www.nature.com/onc ORIGINAL ARTICLE RASSF1A interacts with and activates the mitotic kinase Aurora-A L Liu1, C Guo1, R Dammann2, S Tommasi1 and GP Pfeifer1 1Division of Biology, Beckman Research Institute, City of Hope Cancer Center, Duarte, CA, USA and 2Institute of Genetics, University of Giessen, Giessen, Germany The RAS association domain family 1A (RASSF1A) gene tumorigenesis and carcinogen-induced tumorigenesis is located at chromosome 3p21.3 within a specific area of (Tommasi et al., 2005; van der Weyden et al., 2005), common heterozygous and homozygous deletions. RASS- supporting the notion that RASSF1A is a bona fide F1A frequently undergoes promoter methylation-asso- tumor suppressor. However, it is not fully understood ciated inactivation in human cancers. Rassf1aÀ/À mice how RASSF1A is involved in tumor suppression. are prone to both spontaneous and carcinogen-induced The biochemical function of the RASSF1A protein is tumorigenesis, supporting the notion that RASSF1A is a largely unknown. The homology of RASSF1A with the tumor suppressor. However, it is not fully understood how mammalian Ras effector novel Ras effector (NORE)1 RASSF1A is involved in tumor suppression pathways. suggests that the RASSF1A gene product may function Here we show that overexpression of RASSF1A inhibits in signal transduction pathways involving Ras-like centrosome separation. RASSF1A interacts with Aurora-A, proteins. However, recent data indicate that RASSF1A a mitotic kinase. Surprisingly, knockdown of RASS- itself binds to RAS only weakly and that binding to F1A by siRNA led to reduced activation of Aurora-A, RAS may require heterodimerization of RASSF1A and whereas overexpression of RASSF1A resulted in in- NORE1 (Ortiz-Vega et al., 2002). -
Proper Division Plane Orientation and Mitotic Progression Together Allow Normal Growth of Maize
Proper division plane orientation and mitotic progression together allow normal growth of maize Pablo Martineza,b, Anding Luoc, Anne Sylvesterc, and Carolyn G. Rasmussena,1 aDepartment of Botany and Plant Sciences, Center for Plant Cell Biology, University of California, Riverside, CA 92521; bBiochemistry and Molecular Biology Graduate Program, University of California, Riverside, CA 92521; and cDepartment of Molecular Biology, University of Wyoming, Laramie, WY 82071 Edited by Elliot M. Meyerowitz, Howard Hughes Medical Institute and California Institute of Technology, Pasadena, CA, and approved January 17, 2017 (received for review November 23, 2016) How growth, microtubule dynamics, and cell-cycle progression are dynamics during mitosis. Similar to mutants with defects in both coordinated is one of the unsolved mysteries of cell biology. A interphase and mitotic microtubule dynamics, maize tan1 mu- maize mutant, tangled1, with known defects in growth and proper tants have short stature and misoriented cell patterns (23), as do division plane orientation, and a recently characterized cell-cycle mutants of TAN1-interacting partners phragmoplast orienting delay identified by time-lapse imaging, was used to clarify the re- kinesin-1;2 (24). TAN1 is similar to the microtubule binding lationship between growth, cell cycle, and proper division plane domain of adenomapolyposis coli (22), a multifunctional protein orientation. The tangled1 mutant was fully rescued by introduction that promotes proper division orientation in animal cells (25–27). of cortical division site localized TANGLED1-YFP. A CYCLIN1B de- In Arabidopsis thaliana, AtTAN1 fused to yellow fluorescent struction box was fused to TANGLED1-YFP to generate a line that protein (YFP) was the first identified positive marker of the cor- mostly rescued the division plane defect but still showed cell-cycle tical division site, remaining at the site after PPB disassembly (20). -
Mitosis Vs. Meiosis
Mitosis vs. Meiosis In order for organisms to continue growing and/or replace cells that are dead or beyond repair, cells must replicate, or make identical copies of themselves. In order to do this and maintain the proper number of chromosomes, the cells of eukaryotes must undergo mitosis to divide up their DNA. The dividing of the DNA ensures that both the “old” cell (parent cell) and the “new” cells (daughter cells) have the same genetic makeup and both will be diploid, or containing the same number of chromosomes as the parent cell. For reproduction of an organism to occur, the original parent cell will undergo Meiosis to create 4 new daughter cells with a slightly different genetic makeup in order to ensure genetic diversity when fertilization occurs. The four daughter cells will be haploid, or containing half the number of chromosomes as the parent cell. The difference between the two processes is that mitosis occurs in non-reproductive cells, or somatic cells, and meiosis occurs in the cells that participate in sexual reproduction, or germ cells. The Somatic Cell Cycle (Mitosis) The somatic cell cycle consists of 3 phases: interphase, m phase, and cytokinesis. 1. Interphase: Interphase is considered the non-dividing phase of the cell cycle. It is not a part of the actual process of mitosis, but it readies the cell for mitosis. It is made up of 3 sub-phases: • G1 Phase: In G1, the cell is growing. In most organisms, the majority of the cell’s life span is spent in G1. • S Phase: In each human somatic cell, there are 23 pairs of chromosomes; one chromosome comes from the mother and one comes from the father. -
The Involvement of Ubiquitination Machinery in Cell Cycle Regulation and Cancer Progression
International Journal of Molecular Sciences Review The Involvement of Ubiquitination Machinery in Cell Cycle Regulation and Cancer Progression Tingting Zou and Zhenghong Lin * School of Life Sciences, Chongqing University, Chongqing 401331, China; [email protected] * Correspondence: [email protected] Abstract: The cell cycle is a collection of events by which cellular components such as genetic materials and cytoplasmic components are accurately divided into two daughter cells. The cell cycle transition is primarily driven by the activation of cyclin-dependent kinases (CDKs), which activities are regulated by the ubiquitin-mediated proteolysis of key regulators such as cyclins, CDK inhibitors (CKIs), other kinases and phosphatases. Thus, the ubiquitin-proteasome system (UPS) plays a pivotal role in the regulation of the cell cycle progression via recognition, interaction, and ubiquitination or deubiquitination of key proteins. The illegitimate degradation of tumor suppressor or abnormally high accumulation of oncoproteins often results in deregulation of cell proliferation, genomic instability, and cancer occurrence. In this review, we demonstrate the diversity and complexity of the regulation of UPS machinery of the cell cycle. A profound understanding of the ubiquitination machinery will provide new insights into the regulation of the cell cycle transition, cancer treatment, and the development of anti-cancer drugs. Keywords: cell cycle regulation; CDKs; cyclins; CKIs; UPS; E3 ubiquitin ligases; Deubiquitinases (DUBs) Citation: Zou, T.; Lin, Z. The Involvement of Ubiquitination Machinery in Cell Cycle Regulation and Cancer Progression. 1. Introduction Int. J. Mol. Sci. 2021, 22, 5754. https://doi.org/10.3390/ijms22115754 The cell cycle is a ubiquitous, complex, and highly regulated process that is involved in the sequential events during which a cell duplicates its genetic materials, grows, and di- Academic Editors: Kwang-Hyun Bae vides into two daughter cells. -
Review Cell Fusion and Some Subcellular Properties Of
REVIEW CELL FUSION AND SOME SUBCELLULAR PROPERTIES OF HETEROKARYONS AND HYBRIDS SAIMON GORDON From the Genetics Laboratory, Department of Biochemistry, The University of Oxford, England, and The Rockefeller University, New York 10021 I. INTRODUCTION The technique of somatic cell fusion has made it first cell hybrids obtained by this method. The iso- possible to study cell biology in an unusual and lation of hybrid cells from such mixed cultures direct way. When cells are mixed in the presence of was greatly facilitated by the Szybalski et al. (6) Sendai virus, their membranes coalesce, the cyto- and Littlefield (7, 8) adaptation of a selective me- plasm becomes intermingled, and multinucleated dium containing hypoxanthine, aminopterin, and homo- and heterokaryons are formed by fusion of thymidine (HAT) to mammalian systems. similar or different cells, respectively (1, 2). By Further progress followed the use of Sendai fusing cells which contrast in some important virus by Harris and Watkins to increase the biologic property, it becomes possible to ask ques- frequency of heterokaryon formation (9). These tions about dominance of control processes, nu- authors exploited the observation by Okada that cleocytoplasmic interactions, and complementa- UV irradiation could be used to inactivate Sendai tion in somatic cell heterokaryons. The multinucle- virus without loss of fusion efficiency (10). It was ate cell may divide and give rise to mononuclear therefore possible to eliminate the problem of virus cells containing chromosomes from both parental replication in fused cells. Since many cells carry cells and become established as a hybrid cell line receptors for Sendai virus, including those of able to propagate indefinitely in vitro. -
Gene Therapy Product Quality Aspects in the Production of Vectors and Genetically Modified Somatic Cells
_____________________________________________________________ 3AB6a ■ GENE THERAPY PRODUCT QUALITY ASPECTS IN THE PRODUCTION OF VECTORS AND GENETICALLY MODIFIED SOMATIC CELLS Guideline Title Gene Therapy Product Quality Aspects in the Production of Vectors and Genetically Modified Somatic Cells Legislative basis Directive 75/318/EEC as amended Date of first adoption December 1994 Date of entry into July 1995 force Status Last revised December 1994 Previous titles/other Gene Therapy Products - Quality, Safety and Efficacy references Aspects in the Production of Vectors and Genetically Modified Somatic Cells/ III/5863/93 Additional Notes This note for guidance is intended to facilitate the collection and submission of data to support applications for marketing authorisation within the EC for gene therapy products derived by biotechnology/high technology and intended for medicinal use in man. CONTENTS 1. INTRODUCTION 2. POINTS TO CONSIDER IN MANUFACTURE 3. DEVELOPMENT GENETICS 4. PRODUCTION 5. PURIFICATION 6. PRODUCT CHARACTERISATION 7. CONSISTENCY AND ROUTINE BATCH CONTROL OF FINAL PROCESSED PRODUCT 8. SAFETY REGULATIONS 275 _____________________________________________________________ 3AB6a ■ GENE THERAPY PRODUCT QUALITY ASPECTS IN THE PRODUCTION OF VECTORS AND GENETICALLY MODIFIED SOMATIC CELLS 1. INTRODUCTION Somatic gene therapy encompasses medical interventions which involve the deliberate modification of the genetic material of somatic cells. Scientific progress over the past decade has led to the development of novel methods for the transfer of new genetic material into patients’ cells. The aims of these methods include the efficient transfer and functional expression or manifestation of the transferred genetic material in a target somatic cell population for therapeutic, prophylactic or diagnostic purposes. Although in the majority of cases the intention is the addition and expression of a gene to yield a protein product, the transfer of nucleic acids with the aim of modifying the function or expression of an endogenous gene, e.g. -
Human Germline Genome Editing: Fact Sheet
Human germline genome editing: fact sheet Purpose • To contribute to evidence-informed discussions about human germline genome editing. KEY TAKEAWAYS • Gene editing offers the potential to improve human health in ways not previously possible. • Making changes to human genes that can be passed on to future generations is prohibited in Australia. • Unresolved questions remain on the possible long-term impacts, unintended consequences, and ethical issues associated with introducing heritable changes by editing of the genome of human gametes (sperm and eggs) and embryos. • AusBiotech believes the focus of human gene editing should remain on non-inheritable changes until such time as the scientific evidence, regulatory frameworks and health care models have progressed sufficiently to warrant consideration of any heritable genetic edits. Gene editing Gene editing is the insertion, deletion, or modification of DNA to modify an organism’s specific genetic characteristics. New and evolving gene editing techniques and tools (e.g. CRISPR) allow editing of genes with a level of precision that increases its applications across the health, agricultural, and industrial sectors. These breakthrough techniques potentially offer a range of different options for treating devastating human diseases and delivering environmentally sustainable food production systems that can feed the world’s growing population, which is expected to exceed nine billion by 2050. The current primary application of human gene editing is on non-reproductive cells (‘somatic’ cells) -
The Kinase Activity of Aurora B Is Required for Kinetochore-Microtubule Interactions During Mitosis
Current Biology, Vol. 12, 894–899, June 4, 2002, 2002 Elsevier Science Ltd. All rights reserved. PII S0960-9822(02)00848-5 The Kinase Activity of Aurora B Is Required for Kinetochore-Microtubule Interactions during Mitosis Maki Murata-Hori and Yu-li Wang1 chromosomal congression, we monitored the move- Department of Physiology ment of individual centromeres in cells expressing a high University of Massachusetts Medical School level of aurora B(K-R)-GFP or control cells expressing a Worcester, Massachusetts 01605 similar level of wild-type aurora B-GFP (Figure 1B). Both aurora B-GFP and aurora B(K-R)-GFP were localized at centromeres and spindle poles [6] and to a less extent Summary along chromosomal arms (see Figures 3A and 3D). In control cells, the centromeres of neighboring chro- As a component of the “chromosomal passenger pro- mosomes moved independently of each other at an av- Ϯ Ϯ ϭ tein complex,” the aurora B kinase is associated with erage rate of 1.8 1.2 m/min (mean SD, n 22), centromeres during prometaphase and with midzone with frequent changes in direction (Figure 1B, left). They ف microtubules during anaphase and is required for both eventually accumulated at the metaphase plate 20 min mitosis and cytokinesis [1–6]. Ablation of aurora B after nuclear envelope breakdown (19/19, Figures 1Aa– causes defects in both prometaphase chromosomal 1Ad; Supplementary Movie 1 available with this article congression and the spindle checkpoint [4–6]; how- online). In contrast, in cells expressing aurora B(K-R)- ever, the mechanisms underlying these defects are GFP, centromeres of neighboring chromosomes moved Ϯ unclear. -
Ran Controls Microtubule Asters and Nuclear Assembly 2455 Chromatin Rounded up (Fig
Journal of Cell Science 112, 2453-2461 (1999) 2453 Printed in Great Britain © The Company of Biologists Limited 1999 JCS0524 Ran-GTP stabilises microtubule asters and inhibits nuclear assembly in Xenopus egg extracts Chuanmao Zhang1,2, Mike Hughes1 and Paul R. Clarke1,* 1Biomedical Research Centre, University of Dundee, Level 5, Ninewells Hospital and Medical School, Dundee DD1 9SY, Scotland, UK 2Department of Cell Biology and Genetics, College of Life Sciences, Peking University, Beijing 100871, China *Author for correspondence (e-mail: [email protected]) Accepted 25 May; published on WWW 24 June 1999 SUMMARY Ran is an abundant GTPase of the Ras superfamily that is nucleus and blocks chromatin decondensation. In contrast, highly conserved in eukaryotes. In interphase cells, Ran is Ran GDP does not stabilise microtubules or inhibit nuclear mainly nuclear and thought to be predominantly GTP- assembly. RanT24N and RanBP1, which oppose the bound, but it is also present in the cytoplasm, probably generation of Ran-GTP by RCC1, arrest nuclear growth GDP-bound. This asymmetric distribution plays an after disappearance of the aster. Ran associates with important role in directing nucleocytoplasmic transport. microtubule asters in egg extracts and with mitotic spindles Ran has also been implicated in cell cycle control, including in somatic Xenopus cells, suggesting that it may affect the transition from mitosis to interphase when the microtubule stability directly. These results show that Ran compartmentalisation of the nucleus is established. Here, has a novel function in the control of microtubule stability we have examined the role of Ran in this transition using that is clearly distinct from nucleocytoplasmic transport. -
The Emerging Role of Ncrnas and RNA-Binding Proteins in Mitotic Apparatus Formation
non-coding RNA Review The Emerging Role of ncRNAs and RNA-Binding Proteins in Mitotic Apparatus Formation Kei K. Ito, Koki Watanabe and Daiju Kitagawa * Department of Physiological Chemistry, Graduate School of Pharmaceutical Science, The University of Tokyo, Bunkyo, Tokyo 113-0033, Japan; [email protected] (K.K.I.); [email protected] (K.W.) * Correspondence: [email protected] Received: 11 November 2019; Accepted: 13 March 2020; Published: 20 March 2020 Abstract: Mounting experimental evidence shows that non-coding RNAs (ncRNAs) serve a wide variety of biological functions. Recent studies suggest that a part of ncRNAs are critically important for supporting the structure of subcellular architectures. Here, we summarize the current literature demonstrating the role of ncRNAs and RNA-binding proteins in regulating the assembly of mitotic apparatus, especially focusing on centrosomes, kinetochores, and mitotic spindles. Keywords: ncRNA; centrosome; kinetochore; mitotic spindle 1. Introduction Non-coding RNAs (ncRNAs) are defined as a class of RNA molecules that are transcribed from genomic DNA, but not translated into proteins. They are mainly classified into the following two categories according to their length—small RNA (<200 nt) and long non-coding RNA (lncRNA) (>200 nt). Small RNAs include traditional RNA molecules, such as transfer RNA (tRNA), small nuclear RNA (snRNA), small nucleolar RNA (snoRNA), PIWI-interacting RNA (piRNA), and micro RNA (miRNA), and they have been studied extensively [1]. Research on lncRNA is behind that on small RNA despite that recent transcriptome analysis has revealed that more than 120,000 lncRNAs are generated from the human genome [2–4].